# Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

> **NCT00492128** · PHASE4 · COMPLETED · sponsor: **Yokohama City University Medical Center** · enrollment: 196 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Losartan/amlodipine or losartan/hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00492128
- **Lead sponsor:** Yokohama City University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-05
- **Final completion:** 2010-08
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492128, "Kanagawa Combination Anti-hypertensive Therapy (K-CAT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00492128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*